Clinical trial
Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With…
NCT00104806 · Wake Forest University Health Sciences, Other · Terminated
Key facts
| NCT number | NCT00104806 |
|---|---|
| Title | Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes |
| Official title | Phase II Trial of Arsenic Trioxide and Dose-Escalated Cholecalciferol in Myelodysplastic Syndrome |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms |
| Intervention type | Dietary Supplement, Drug |
| Interventions | cholecalciferol, arsenic trioxide |
| Enrollment | 5 |
| Start date | Nov 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | May 1, 2010 |
| First posted | Mar 4, 2005 |
| Last update posted | Aug 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: